These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19915239)

  • 1. Prescription auditing of griseofulvin in a tertiary care teaching hospital.
    Bai Kirubha MH
    Indian J Dermatol Venereol Leprol; 2009; 75(6):588-92. PubMed ID: 19915239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
    Faergemann J; Mörk NJ; Haglund A; Odegård T
    Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
    Foster KW; Friedlander SF; Panzer H; Ghannoum MA; Elewski BE
    J Am Acad Dermatol; 2005 Nov; 53(5):798-809. PubMed ID: 16243128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study.
    Voravutinon V
    J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
    Dastghaib L; Azizzadeh M; Jafari P
    J Dermatolog Treat; 2005 Feb; 16(1):43-6. PubMed ID: 15897167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of dermatophytosis with new systemic antifungal agent, itraconazole.
    Noppakun N; Phuphaibool K
    J Med Assoc Thai; 1992 Feb; 75(2):99-103. PubMed ID: 1322949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on rational drug prescribing and dispensing in outpatients in a tertiary care teaching hospital of Western Nepal.
    Alam K; Mishra P; Prabhu M; Shankar PR; Palaian S; Bhandari RB; Bista D
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):436-43. PubMed ID: 18603950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Griseofulvin].
    Develoux M
    Ann Dermatol Venereol; 2001 Dec; 128(12):1317-25. PubMed ID: 11908134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teaching exercise of drug utilization by medical students.
    Das BP; Sethi A; Nutan K; Gunjan
    JNMA J Nepal Med Assoc; 2005; 44(160):160-4. PubMed ID: 18380068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis.
    Svejgaard E
    Acta Derm Venereol; 1985; 65(2):143-9. PubMed ID: 2408417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical griseofulvin in treatment of tinea corporis.
    Kassem MA; Esmat S; Bendas ER; El-Komy MH
    Mycoses; 2006 May; 49(3):232-5. PubMed ID: 16681816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personal hygiene as an alternative to griseofulvin in the treatment of tinea cruris.
    Akinwale SO
    Afr J Med Med Sci; 2000 Mar; 29(1):41-3. PubMed ID: 11379466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous fungal infections in the United States: Analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995-2004.
    Panackal AA; Halpern EF; Watson AJ
    Int J Dermatol; 2009 Jul; 48(7):704-12. PubMed ID: 19570075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
    Gupta AK; Ryder JE; Johnson AM
    Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
    Angello JT; Voytovich RM; Jan SA
    Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.
    Cole GW; Stricklin G
    Arch Dermatol; 1989 Nov; 125(11):1537-9. PubMed ID: 2684023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription.
    Potocki M; Goette J; Szucs TD; Nadal D
    Infection; 2003 Dec; 31(6):398-403. PubMed ID: 14735382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of griseofulvin and itraconazole in the treatment of experimentally induced dermatophytosis in cats.
    Moriello KA; DeBoer DJ
    J Am Vet Med Assoc; 1995 Aug; 207(4):439-44. PubMed ID: 7591941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.